Medical News
Prognostic Impact of Admission High-sensitivity C-reactive P...
Cardiovasc Diabetol.
This study shows that hs-CRP predicts in-hospital outcome and two-year mortality in AMI patients with and without...
23 Oct 2020
The Effect of Revascularization on Mortality and Risk of Ven...
BMC Cardiovasc Disord.
Revascularization may be beneficial in preventing recurrent ventricular arrhythmia, and should be considered as...
22 Oct 2020
Blood Pressure Levels and Cardiovascular Risk according to A...
Cardiovasc Diabetol.
In a cohort of hypertensive patients who had DM but no history of cardiovascular disease, lower BP was associated...
21 Oct 2020
Increased plaque rupture forms peak incidence of acute myoca...
Int J Cardiol.
The peak incidence of AMI in the winter is formed by increased plaque rupture, suggesting environmental temperature...
21 Oct 2020
eCMEs
Key Trials
Meta-analysis on the Efficacy and Safety of Sacubitril/valsartan in Heart Failure
According to this meta-analysis, sacubitril/valsartan, as compared with ACE inhibitors or ARBs, was associated with reduced risk of all-cause and CV...
Coadministration of Telmisartan/amlodipine and Rosuvastatin Safe and Effective in Hypertensive Patients with Dyslipidemia
Combined administration of telmisartan/amlodipine 80/5 mg and rosuvastatin 20 mg significantly reduced blood pressure and improved lipid control in...
TRANSITION: Impact of Sacubitril/valsartan on NT-proBNP in Hospitalized HFrEF Patients
This post hoc analysis of TRANSITION study demonstrated a rapid and significant reduction in NT-proBNP, and favourable outcomes in patients with...
Impact of Glucose-lowering Drugs or Strategies on CV Events in Individuals with or at Risk of T2DM
This updated systematic review and meta-analysis demonstrated that use of glucose lowering drugs or strategies reduced the risk of fatal and non-...
Slide Library
Medical Management Strategy of CTEPH: Role of Riociguat
Riociguat, a stimulator of soluble guanylate cyclase, has been globally approved for the treatment of PAH and inoperable CTEPH and persistent/...
Macitentan: 1st ERA Proven to Reduce Morbidity and Mortality in PAH
Macitentan is an orally active, potent, tissue targeting ERA that is indicated for the treatment of pulmonary arterial hypertension (PAH). It is the...
Chronic Thromboembolic Pulmonary Hypertension
Chronic thromboembolic pulmonary hypertension (CTEPH) is the presence of mean pulmonary artery pressure (mPAP) ≥ 25 mmHg following an episode of...
Diabetic Dyslipidemia
Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...
Our Publications
Telyse (Tenecteplase) Monograph
In the management of STEMI in India, pharmacoinvasive strategy involving thrombolytics is the preferred therapy in cases of delays in primary PCI....
Mexiletine FAQ Booklet
Mexiletine is a class 1B antiarrhythmic agent, which blocks the sodium channels and is indicated in suppression of ventricular arrhythmias. The...
Mexohar (Mexiletine) Monograph
About 5% of patients with cardiac arrhythmias or with heart failure are diagnosed with a ventricular tachycardia. Recurrent Ventricular Tachycardia...
Gutron (Midodrine hydrochloride) Monograph
Orthostatic Hypotension is common in elderly (>70 years of age) and can also occur secondary to neuropathy like in diabetes or central lesions...
Patient Education
Understanding Angioplasty
Angioplasty is a life-saving procedure to open up blocked or narrowed blood vessels. This document gives a brief idea about the procedure.
Understanding Obesity
This document explains what is obesity, what is the impact of obesity on overall health and what are the benefits of weight loss.
Hypertension
Know more about the risk factors, associated ill-effects and tips for management of hypertension or high blood pressure.
.jpg)
Poll
What percent of your patients who need oral anticoagulation, receive warfarin?
<20%
20-40%
40-50%
50-70%
70-80%
Almost all
Total votes: 22
